Avalon Pharmaceuticals Announces Special Meeting Date

GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that it has scheduled a special meeting of stockholders for Thursday, May 28, 2009, to consider and vote upon a proposal to adopt an agreement and plan of merger and reorganization, dated as of October 27, 2008, as amended, which provides for the acquisition of Avalon by Clinical Data, Inc (Nasdaq:CLDA). The proposed acquisition of Avalon by Clinical Data was previously announced on October 28, 2008.